Bo Hao

1.2k total citations · 1 hit paper
36 papers, 790 citations indexed

About

Bo Hao is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Bo Hao has authored 36 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 14 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Bo Hao's work include Ferroptosis and cancer prognosis (12 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Cancer-related molecular mechanisms research (6 papers). Bo Hao is often cited by papers focused on Ferroptosis and cancer prognosis (12 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Cancer-related molecular mechanisms research (6 papers). Bo Hao collaborates with scholars based in China. Bo Hao's co-authors include Qing Geng, Wenyang Jiang, Ruyuan He, Heng Meng, Weichen Lin, Bohao Liu, Zhihua Geng, Ning Li, Rui Xiong and Tao Fan and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Medicine.

In The Last Decade

Bo Hao

34 papers receiving 784 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Itaconate inhibits ferroptosis of macrophage via Nrf2 pathways against sepsis-induced acute lung injury

2022 177 citations Ruyuan He, Bohao Liu et al. profile →

Peers

Bo Hao

PRM

ONCOL

IMMUN

Armando Patrizio Italy

Sebastiano Cicco Italy

Zhiqiao Zhang China

Ernesta Cavalcanti Italy

Zoltán Lohinai Hungary

Angelica Petrillo Italy

Yukimasa Hatachi Japan

Alessandro Inno Italy

Nikolaos Syrigos Greece

Yongjun Guan China

Armando Patrizio Italy

Bo Hao

246 ×0.9

133 ×0.5

PRM

273 ×1.4

ONCOL

74 ×0.4

161 ×1.0

IMMUN

Citations per year, relative to Bo Hao Bo Hao (= 1×) peers Armando Patrizio

Countries citing papers authored by Bo Hao

Since Specialization

Citations

This map shows the geographic impact of Bo Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Hao more than expected).

Fields of papers citing papers by Bo Hao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Hao. The network helps show where Bo Hao may publish in the future.

Co-authorship network of co-authors of Bo Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Hao. A scholar is included among the top collaborators of Bo Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Hao. Bo Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Hongxia, et al.. (2025). Multi-omics characterization of cachexia-related genes reveals prognostic signatures and immune landscape in breast cancer. Clinical & Translational Oncology. 28(2). 557–574.

Hu, Haihong, et al.. (2025). Single-Cell Sequence and Machine Learning Identify a CD79A+B Cells-Related Transcriptional Signature for Predicting Clinical Outcomes and Immune Microenvironment in Breast Cancer. Cancer Informatics. 24. 2693987235–2693987235.

Tang, Yamei, Haihong Hu, Bo Hao, et al.. (2025). Multi-omics analysis revealed the novel role of NQO1 in microenvironment, prognosis and immunotherapy of hepatocellular carcinoma. Scientific Reports. 15(1). 8591–8591. 2 indexed citations

Song, Congkuan, Wenjie Wang, Bohao Liu, et al.. (2024). Comprehensive analysis of m6A modification in lipopolysaccharide-induced acute lung injury in mice. Molecular Medicine. 30(1). 14–14. 4 indexed citations

Hu, Haihong, Hongxia Zhu, Bo Hao, et al.. (2024). Integration of multiomics analyses reveals unique insights into CD24-mediated immunosuppressive tumor microenvironment of breast cancer. Inflammation Research. 73(6). 1047–1068. 2 indexed citations

Zhu, Hongxia, Haihong Hu, Bo Hao, et al.. (2024). Insights into a Machine Learning-Based Palmitoylation-Related Gene Model for Predicting the Prognosis and Treatment Response of Breast Cancer Patients. Technology in Cancer Research & Treatment. 23. 2234005322–2234005322. 4 indexed citations

Hao, Bo, et al.. (2024). Single-cell analysis reveals the disparities in immune profiles between younger and elder patients. European Geriatric Medicine. 15(5). 1509–1522. 1 indexed citations

Hao, Bo, et al.. (2024). Identification of SLC2A1 as a predictive biomarker for survival and response to immunotherapy in lung squamous cell carcinoma. Computers in Biology and Medicine. 171. 108183–108183. 26 indexed citations

Hu, Haihong, et al.. (2024). Development of machine learning-based malignant pericardial effusion-related model in breast cancer: Implications for clinical significance, tumor immune and drug-therapy. Heliyon. 10(5). e27507–e27507. 1 indexed citations

10.

Hao, Bo, Fang Li, Xiaoxia Wan, et al.. (2022). Squamous cell carcinoma predicts worse prognosis than adenocarcinoma in stage IA lung cancer patients: A population-based propensity score matching analysis. Frontiers in Surgery. 9. 944032–944032. 6 indexed citations

11.

Pan, Shize, Congkuan Song, Heng Meng, et al.. (2022). Identification of cuproptosis-related subtypes in lung adenocarcinoma and its potential significance. Frontiers in Pharmacology. 13. 934722–934722. 11 indexed citations

12.

Song, Congkuan, Zilong Lu, Donghang Li, et al.. (2022). Identification of an inflammatory response signature associated with prognostic stratification and drug sensitivity in lung adenocarcinoma. Scientific Reports. 12(1). 10110–10110. 5 indexed citations

13.

Hao, Bo, Zilong Lu, Juan Xiong, et al.. (2022). Single-cell RNA sequencing analysis revealed cellular and molecular immune profiles in lung squamous cell carcinoma. Translational Oncology. 27. 101568–101568. 18 indexed citations

14.

Pan, Shize, Lei Chen, Tao Fan, et al.. (2022). Comprehensive molecular analysis of a four-pyroptosis-gene signature with prognosis and immune landscape in lung adenocarcinoma. Genomics. 114(3). 110355–110355. 6 indexed citations

15.

Hao, Bo, et al.. (2022). Toripalimab: the First Domestic Anti-Tumor PD-1 Antibody in China. Frontiers in Immunology. 12. 730666–730666. 58 indexed citations

16.

Hao, Bo, Lin Zhang, Tao Fan, et al.. (2020). Survival Following Segmentectomy or Lobectomy in Patients With Stage IB Non-small-cell Lung Cancer. Frontiers in Oncology. 10. 661–661. 3 indexed citations

17.

Meng, Heng, Rui Xiong, Ruyuan He, et al.. (2020). CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan, China. Journal of Infection. 81(1). e33–e39. 182 indexed citations

18.

Fan, Tao, Bo Hao, Bo Shen, et al.. (2020). Nomogram for Predicting COVID-19 Disease Progression Based on Single-Center Data: Observational Study and Model Development. JMIR Medical Informatics. 8(9). e19588–e19588. 6 indexed citations

19.

Yu, Miaomei, Bo Hao, Yuxia Zhan, & Guanghua Luo. (2018). Krüppel-like factor 4 expression in solid tumor prognosis: A meta-analysis. Clinica Chimica Acta. 485. 50–59. 14 indexed citations

20.

Wan, Xin, et al.. (2012). All-trans Retinoic Acid Protects Renal Tubular Epithelial Cells Against Hypoxia Induced Injury In Vitro. Transplantation Proceedings. 45(2). 497–502. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact